DE69017690T2 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
DE69017690T2
DE69017690T2 DE69017690T DE69017690T DE69017690T2 DE 69017690 T2 DE69017690 T2 DE 69017690T2 DE 69017690 T DE69017690 T DE 69017690T DE 69017690 T DE69017690 T DE 69017690T DE 69017690 T2 DE69017690 T2 DE 69017690T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
delivery
compositions
lysophosphatidyl
calcitonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017690T
Other languages
English (en)
Other versions
DE69017690D1 (de
Inventor
Lisbeth Illum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Application granted granted Critical
Publication of DE69017690D1 publication Critical patent/DE69017690D1/de
Publication of DE69017690T2 publication Critical patent/DE69017690T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
DE69017690T 1989-08-18 1990-08-16 Pharmazeutische zusammensetzungen. Expired - Fee Related DE69017690T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898918879A GB8918879D0 (en) 1989-08-18 1989-08-18 Pharmaceutical compositions
PCT/GB1990/001293 WO1991002545A1 (en) 1989-08-18 1990-08-16 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69017690D1 DE69017690D1 (de) 1995-04-13
DE69017690T2 true DE69017690T2 (de) 1995-10-19

Family

ID=10661831

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017690T Expired - Fee Related DE69017690T2 (de) 1989-08-18 1990-08-16 Pharmazeutische zusammensetzungen.

Country Status (10)

Country Link
EP (1) EP0487562B1 (de)
JP (1) JPH04507412A (de)
KR (1) KR920703112A (de)
AT (1) ATE119398T1 (de)
CA (1) CA2059523C (de)
DE (1) DE69017690T2 (de)
DK (1) DK0487562T3 (de)
ES (1) ES2072442T3 (de)
GB (2) GB8918879D0 (de)
WO (1) WO1991002545A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10248601A1 (de) * 2002-10-17 2004-05-06 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DK36492D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Praeparat
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
ES2218543T3 (es) 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US7625865B2 (en) 2004-03-26 2009-12-01 Universita Degli Studi Di Parma Insulin highly respirable microparticles
MX2009008582A (es) 2007-02-11 2009-10-30 Map Pharmaceuticals Inc Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.
US7791198B2 (en) 2007-02-20 2010-09-07 Nec Electronics Corporation Semiconductor device including a coupling region which includes layers of aluminum and copper alloys

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
EP0248051A1 (de) * 1985-11-29 1987-12-09 FISONS plc Natriumcromoglycat enthaltende pharmazeutische zusammensetzung
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10248601A1 (de) * 2002-10-17 2004-05-06 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems

Also Published As

Publication number Publication date
GB2251188B (en) 1993-04-28
WO1991002545A1 (en) 1991-03-07
CA2059523A1 (en) 1991-02-19
EP0487562B1 (de) 1995-03-08
DK0487562T3 (da) 1995-05-22
ATE119398T1 (de) 1995-03-15
JPH04507412A (ja) 1992-12-24
EP0487562A1 (de) 1992-06-03
GB2251188A (en) 1992-07-01
CA2059523C (en) 1999-04-27
GB9203051D0 (en) 1992-03-25
KR920703112A (ko) 1992-12-17
GB8918879D0 (en) 1989-09-27
ES2072442T3 (es) 1995-07-16
DE69017690D1 (de) 1995-04-13

Similar Documents

Publication Publication Date Title
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
DE69001730T2 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
NL194828B (nl) Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
DE69115263T2 (de) Pharmazeutische zusammensetzungen.
DE58901934D1 (de) Verschlussanordnung fuer pharmazeutische flaschen.
DE69833464D1 (de) Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
NO180584C (no) Bisnaftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler, samt farmasöytiske preparater
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
SE9704546D0 (sv) Novel compounds
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
DE69017690D1 (de) Pharmazeutische zusammensetzungen.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
DE68915203D1 (de) Pharmazeutische Mischungen.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
FI920845A0 (fi) Farmaceutiska kompositioner innehaollande interleukin-2.
DE69003003T2 (de) Pharmazeutische Zusammensetzung.
IT8922398A0 (it) Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINI

8339 Ceased/non-payment of the annual fee